<DOC>
	<DOCNO>NCT01466959</DOCNO>
	<brief_summary>An alternative systemic heparin anticoagulation HD citrate dialysate ( CD ) . CD contain small amount citric acid rather acetic acid acidify agent . The use citrasate may lead low heparin requirement hemodialysis . This randomized , double blind , two-period crossover trial HD patient compare effect citrasate dialysis ( CD ) usual acetic-acid base dialysate ( AD ) heparin dose .</brief_summary>
	<brief_title>The Effect Citrasate Dialysate Heparin Dose Hemodialysis</brief_title>
	<detailed_description>The investigator perform randomize , double-blind , two-period crossover trial chronic HD patient compare effect citrasate dialysate ( CD ) usual acetic-acid base dialysate ( AD ) cumulative intradialytic heparin dose . There four week run phase follow two week intervention AD CD follow remain AD CD intervention . The primary outcome change intradialytic heparin dose achieve citrasate compare acetate dialysate . Secondary outcome effect CD compare AD systemic anticoagulation , bleed time HD , metabolic parameter , dialysis adequacy , inflammation , hemodynamic stability , intra-rater inter-rater reliability dialyzer clot score .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Retinol acetate</mesh_term>
	<criteria>chronic stable HD patient â‰¥ 18 year HD least three time per week least 3 month contraindication heparin currently use heparinfree HD know clot disorder warfarin therapy dialyze dysfunctional central venous catheter ( blood flow rate consistently less 300mL/min and/or frequent use thrombolytic ) history vascular access dysfunction plan vascular access conversion procedure study period use high calcium dialysate active medical issue require hospitalization plan kidney transplant study period plan conversion dialysis modality ( peritoneal dialysis , nocturnal dialysis ) study period unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>dialysate</keyword>
	<keyword>acetate base dialysate</keyword>
	<keyword>citrasate dialysate</keyword>
	<keyword>heparin anticoagulation</keyword>
	<keyword>hemodynamic stability</keyword>
</DOC>